18% growth, repeat demand: 2 stocks riding India’s Rs 4.9 lakh cr disposable medtech boom

India's medical-device opportunity is becoming broader than high-value machines such as imaging systems, robotic surgery platforms and advanced diagnostic equipment.

Key points

• #1 Poly Medicure Limited: The Disposable Manufacturer Becomes a Broader Medtech Platform.
• While diagnostic and laboratory disposables are projected to be the fastest-growing segment, sterilisation supplies were the largest segment in 2023.
• For readers, the key questions are which medical-disposable categories Indian listed firms can competitively manufacture, their potential market share, and the resulting revenue and profits.

Fortune Business Insights estimates India's medical devices market at USD 16.16 billion in 2025, rising to USD 17.86 billion in 2026 and USD 44.76 billion by 2034, implying a 12.2% CAGR. The opportunity becomes particularly relevant in disposables: Grand View Research estimates India's medical disposables market at USD 15.88 billion in 2023, with revenue projected to reach USD 51.42 billion (₹4.9 lakh crores) by 2030, representing an 18.3% CAGR.

While diagnostic and laboratory disposables are projected to be the fastest-growing segment, sterilisation supplies were the largest segment in 2023. Grand View Research's latest India data additionally covers wound management, drug delivery, diagnostic and laboratory disposables, dialysis disposables, respiratory supplies and other categories, showing that the market is much broader than syringes and gloves.

For readers, the key questions are which medical-disposable categories Indian listed firms can competitively manufacture, their potential market share, and the resulting revenue and profits. The investment lens therefore shifts to volume, pricing, margins, capital intensity, cash generation and valuation, with Poly Medicure and Molbio Diagnostics offering distinct exposure.

Poly Medicure Limited (Polymed) has built a broad medical-device portfolio covering infusion therapy, vascular access, blood collection and management, anaesthesia and respiratory care, dialysis, surgery and wound drainage, gastroenterology and urology.

In short, 18% growth, repeat demand: 2 stocks riding India's Rs 4.9 lakh cr is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.